Anlotinib, free base | B2156

Anlotinib (AL3818) is a novel multitarget tyrosine kinase inhibitor, inhibiting tumor angiogenesis and proliferative signaling. Potential antineoplastic and anti-angiogenic agent.

Anlotinib (AL3818) is a novel multitarget tyrosine kinase inhibitor, inhibiting tumor angiogenesis and proliferative signaling. Potential antineoplastic and anti-angiogenic agent.

B2156 | Anlotinib, free base DataSheet

Alternate Name/Synonyms: 1-(((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinolin-7-yl)oxy)methyl)cyclopropan-1-amine; AL3818

Appearance: Cystalline solid

Formulation: N/A

CAS Number: 1058156-90-3

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₂₃H₂₂FN₃O₃

Molecular Weight: 407.44

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: DMSO

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A novel multitarget tyrosine kinase inhibitor

MDL Number: N/A

PubChem CID: 25017411

SMILES: CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC

InChi: InChI=1S/C23H22FN3O3/c1-13-9-15-16(27-13)3-4-19(22(15)24)30-18-5-8-26-17-11-21(20(28-2)10-14(17)18)29-12-23(25)6-7-23/h3-5,8-11,27H,6-7,12,25H2,1-2H3

InChi Key: KSMZEXLVHXZPEF-UHFFFAOYSA-N